Avid Bioservices

Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company, which is engaged in providing contract manufacturing services for third party customers on a fee-for-service basis while also supporting its internal drug development efforts. The Company delivers pharmaceutical products through its contract manufacturing business and through licensing its development-stage immunotherapy products. Avid provides a comprehensive range of process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.

Company Growth (employees)
Type
Public
HQ
Tustin, US
Founded
1981
Size (employees)
319 (est)
Avid Bioservices was founded in 1981 and is headquartered in Tustin, US

Key People/Management at Avid Bioservices

Roger Lias

Roger Lias

President and Chief Executive Officer
Paul Lytle

Paul Lytle

CFO

Avid Bioservices Office Locations

Avid Bioservices has an office in Tustin
Tustin, US (HQ)
14282 Franklin Ave
Show all (1)

Avid Bioservices Financials and Metrics

Avid Bioservices Financials

Avid Bioservices's revenue was reported to be $44.7 m in FY, 2016
USD

Revenue (Q2, 2018)

12.8 m

Gross profit (Q2, 2018)

(3.5 m)

Gross profit margin (Q2, 2018), %

(27%)

Net income (Q2, 2018)

(12.6 m)

EBIT (Q2, 2018)

(12.6 m)

Market capitalization (22-Dec-2017)

179 m

Cash (31-Oct-2017)

27.7 m
Avid Bioservices's current market capitalization is $179 m.
USDFY, 2014FY, 2015FY, 2016

Revenue

22.4 m26.8 m44.7 m

Revenue growth, %

20%67%

R&D expense

59.5 m

General and administrative expense

18.6 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Revenue

7.4 m3.9 m5.5 m6.3 m5.7 m9.7 m9.5 m6.7 m5.6 m23.4 m10.7 m12.8 m

Cost of goods sold

16.2 m

Gross profit

(3.5 m)

Gross profit Margin, %

(27%)
USDFY, 2014FY, 2015FY, 2016FY, 2017

Cash

77.5 m68 m61.4 m

Inventories

5.5 m7.4 m16.2 m33.1 m

Current Assets

85.8 m80.5 m81.8 m

PP&E

2.4 m15.1 m24.3 m
USDQ2, 2014Q3, 2014Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Cash

44.4 m63.2 m55.2 m59 m72 m67.5 m44.2 m49.1 m41.5 m37.3 m27.7 m

Inventories

4 m5.2 m6.1 m10.5 m12.6 m15.2 m25.3 m25.9 m33.8 m24.2 m16.5 m

Current Assets

51.3 m72.2 m68.6 m72.3 m89.5 m93.6 m78.2 m82.8 m83 m70.8 m49 m

PP&E

2.3 m2.5 m9 m18.4 m21.8 m23.8 m24.3 m24 m24.1 m24.4 m27.1 m
    USDFY, 2014FY, 2015FY, 2016FY, 2017

    Net Income

    (35.4 m)(50.4 m)(55.7 m)(28.2 m)

    Depreciation and Amortization

    986 k1 m1.5 m2.5 m

    Inventories

    (1.2 m)(1.8 m)(8.8 m)(16.9 m)

    Accounts Payable

    (391 k)3.3 m(3.5 m)(3.3 m)
    USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

    Net Income

    (7.8 m)(9.7 m)(13.1 m)(25.2 m)(13 m)(13.7 m)(13.2 m)(16.8 m)(11.1 m)(4.1 m)(7.8 m)

    Depreciation and Amortization

    277 k542 k

    Inventories

    (468 k)151 k6.1 m10.5 m12.6 m15.2 m25.3 m25.9 m33.8 m

    Accounts Payable

    2.5 m484 k6.8 m9.8 m6.9 m7.8 m9.1 m11.6 m7.7 m
    USDY, 2017

    Revenue/Employee

    40.1 k

    Financial Leverage

    1.8 x
    Show all financial metrics

    Avid Bioservices Operating Metrics

    FY, 2016

    Phase 1/2

    1
    Show all operating metrics

    Avid Bioservices Market Value History

    Avid Bioservices Revenue Breakdown

    Avid Bioservices's Web-traffic and Trends

    Avid Bioservices Company Life and Culture

    You may also be interested in